(Q45722197)

English

Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

based on heuristic

inferred from title

Michel J. Tremblay

5

object named as

Michel J Tremblay

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3

object named as

Réjean Cantin

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Martine Losier

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Jean François Fortin

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Michel G Bergeron

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

111-118

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Energetics of the HIV gp120-CD4 binding reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The acquisition of host-encoded proteins by nascent HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of cytokines and pharmacologic agents on chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-induced immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intercellular adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp 120: identification of a very early fusion-independent event as a neutralization target

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 attachment: another look.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiviral activity of antibodies in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

gp120: Biologic aspects of structural features

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1521-6616(03)00093-7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45722197&oldid=2078946909"